NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $979,000 | +13.0% | 5,908 | -4.8% | 0.00% | 0.0% |
| Q1 2021 | $866,000 | -53.7% | 6,208 | -42.6% | 0.00% | -50.0% |
| Q4 2020 | $1,872,000 | +24.9% | 10,812 | +0.5% | 0.01% | +14.3% |
| Q3 2020 | $1,499,000 | +16.6% | 10,762 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $1,286,000 | +20.1% | 10,762 | +0.5% | 0.01% | -14.3% |
| Q1 2020 | $1,071,000 | -14.1% | 10,712 | +0.9% | 0.01% | +16.7% |
| Q4 2019 | $1,247,000 | +17.5% | 10,612 | -37.5% | 0.01% | 0.0% |
| Q1 2019 | $1,061,000 | -25.2% | 16,972 | -53.4% | 0.01% | -33.3% |
| Q4 2018 | $1,418,000 | -36.8% | 36,459 | -7.4% | 0.01% | -25.0% |
| Q3 2018 | $2,245,000 | +964.0% | 39,381 | +1596.0% | 0.01% | +1100.0% |
| Q3 2017 | $211,000 | – | 2,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |